General
Preferred name
DIPRENORPHINE
Synonyms
[3H]diprenorphine ()
M. 5050 ()
M5050 ()
M-5050 ()
Diprenorfin ()
M50-50 Injection ()
Revivon ()
[3H]diprenorphine ()
P&D ID
PD016119
CAS
14357-78-9
Tags
drug candidate
natural product
drug
available
Drug Status
illicit
approved
vet_approved
Approved by
FDA
Drug indication
Discovery agent
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
INDICATION
Diprenorphine is indicated to reverse the effects of powerful opioids including etorphine and carfentanil, often used for tranquilizing large animals. This drug is not approved for use in humans.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
10
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugBank
DrugBank Approved Drugs
DrugCentral
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
26
Molecular Weight
425.26
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
8
Aromatic Ring Count
1
cLogP
3.39
TPSA
62.16
Fraction CSP3
0.77
Chiral centers
6.0
Largest ring
6.0
QED
0.77
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
